GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cormedix Inc (STU:19KA) » Definitions » Price-to-Funds-From-Operations

Cormedix (STU:19KA) Price-to-Funds-From-Operations : (As of Mar. 04, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Cormedix Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Cormedix Business Description

Industry
Traded in Other Exchanges
Address
300 Connell Drive, Suite 4200, Berkeley Heights, NJ, USA, 07922
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.